CL2011001539A1 - Compuestos derivados de un acido graso poliinsaturado omega 3 u omega 6 y un ester de diol con actividad anti-inflamatoria y antibacteriana; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento del acne o la dermatitis seborreica. - Google Patents

Compuestos derivados de un acido graso poliinsaturado omega 3 u omega 6 y un ester de diol con actividad anti-inflamatoria y antibacteriana; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento del acne o la dermatitis seborreica.

Info

Publication number
CL2011001539A1
CL2011001539A1 CL2011001539A CL2011001539A CL2011001539A1 CL 2011001539 A1 CL2011001539 A1 CL 2011001539A1 CL 2011001539 A CL2011001539 A CL 2011001539A CL 2011001539 A CL2011001539 A CL 2011001539A CL 2011001539 A1 CL2011001539 A1 CL 2011001539A1
Authority
CL
Chile
Prior art keywords
omega
compounds
acne
inflammatory
treatment
Prior art date
Application number
CL2011001539A
Other languages
English (en)
Inventor
Daniel Redoules
Sylvie Daunes-Marion
Marie-Francoise Aries
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011001539(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of CL2011001539A1 publication Critical patent/CL2011001539A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

UN COMPUESTO DE LA SIGUIENTE FÓRMULA GENERAL (1): CARACTERIZADO PORQUE: - N ES UN NÚMERO ENTERO ENTRE 1 Y 15, - M ES 0, 1, 203, Y - R ES LA CADENA DE HIDROCARBURO DE UN ÁCIDO GRASO POLIINSATURADO SELECCIONADO DE ÁCIDOS GRASOS POLIINSATURADOS OMEGA-3 Y OMEGA-6, EN DONDE SE PROPONE TRATAR ACNÉ O DERMATITIS SEBORREICA.        
CL2011001539A 2008-12-22 2011-06-21 Compuestos derivados de un acido graso poliinsaturado omega 3 u omega 6 y un ester de diol con actividad anti-inflamatoria y antibacteriana; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento del acne o la dermatitis seborreica. CL2011001539A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0858967A FR2940281B1 (fr) 2008-12-22 2008-12-22 Ester de diol et d'acide gras polyinsature comme agent anti-acne

Publications (1)

Publication Number Publication Date
CL2011001539A1 true CL2011001539A1 (es) 2011-10-14

Family

ID=40875013

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011001539A CL2011001539A1 (es) 2008-12-22 2011-06-21 Compuestos derivados de un acido graso poliinsaturado omega 3 u omega 6 y un ester de diol con actividad anti-inflamatoria y antibacteriana; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento del acne o la dermatitis seborreica.

Country Status (27)

Country Link
US (1) US8623916B2 (es)
EP (1) EP2379484B1 (es)
JP (1) JP5587333B2 (es)
KR (1) KR101676055B1 (es)
CN (1) CN102256930B (es)
AU (1) AU2009331526B2 (es)
BR (1) BRPI0923494B1 (es)
CA (1) CA2747681C (es)
CL (1) CL2011001539A1 (es)
CO (1) CO6390033A2 (es)
ES (1) ES2424088T3 (es)
FR (1) FR2940281B1 (es)
GE (1) GEP20135820B (es)
HK (1) HK1163655A1 (es)
IL (1) IL213646A (es)
MA (1) MA32810B1 (es)
MX (1) MX2011006659A (es)
MY (1) MY151002A (es)
NZ (1) NZ593781A (es)
PL (1) PL2379484T3 (es)
PT (1) PT2379484E (es)
RU (1) RU2524779C2 (es)
SG (1) SG172342A1 (es)
TN (1) TN2011000237A1 (es)
UA (1) UA103645C2 (es)
WO (1) WO2010072738A1 (es)
ZA (1) ZA201103509B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103857440B (zh) 2011-06-22 2018-09-25 维奥姆生物科学有限公司 基于缀合物的抗真菌和抗细菌前药
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CN105611919A (zh) * 2013-08-08 2016-05-25 盖尔德姆疗法有限公司 包含胆汁酸-脂肪酸缀合物的抗痤疮组合物
FR3033135B1 (fr) 2015-02-27 2018-03-16 Pierre Fabre Dermo-Cosmetique Association d'un retinoide et d'un ester de diol et d'acide gras polyinsature
FR3053253B1 (fr) * 2016-07-01 2020-01-17 Pierre Fabre Dermo-Cosmetique Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5534762B2 (es) 1975-02-07 1980-09-09
DE4240674C2 (de) 1992-11-26 1999-06-24 Schuelke & Mayr Gmbh Desodorierende Wirkstoffe
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH09110818A (ja) * 1995-10-16 1997-04-28 Sanshin Chem Ind Co Ltd １−エチル−３−（３−ジメチルアミノプロピル）カルボジイミド塩酸塩の製造方法
ATE220318T1 (de) 1996-02-21 2002-07-15 Stoa Sa Kosmetische, dermopharmazeutische oder tierärztliche zusammensetzungen zur antiseptischen behandlung von menschlicher oder tierischer haut
GB9620248D0 (en) * 1996-09-26 1996-11-13 Scotia Holdings Plc Esters of unsaturated fatty acids
GB9622636D0 (en) 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
AU6605500A (en) * 1999-07-06 2001-01-22 Regents Of The University Of California, The Methods for the amelioration of neuropsychiatric disorders by inhibiting the inactivating transport of endogenous cannabinoid substances
GB9927629D0 (en) * 1999-11-24 2000-01-19 Croda Int Plc Compounds
EP1269983B1 (de) 2001-06-22 2003-09-10 Dragoco Gerberding & Co Aktiengesellschaft Verwendung von 1,2-Decandiol gegen Körpergeruch verursachende Keime
US20070265352A1 (en) 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
DE10206759A1 (de) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
SE0301862D0 (sv) 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
DE102004031210A1 (de) * 2004-06-28 2006-02-09 Trommsdorff Gmbh & Co. Kg MLV-Kosmetikum
DE10341179A1 (de) 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
US7935732B2 (en) 2004-04-08 2011-05-03 Isp Investments Inc. Antimicrobial compositions
WO2005103171A1 (en) * 2004-04-27 2005-11-03 Akzo Nobel Coatings International B.V. Pigmented strip paint
JP2006056795A (ja) * 2004-08-18 2006-03-02 Suntory Ltd ６−ｏ−ｐｕｆａアスコルビン酸エステルを含有する皮膚化粧料並びに飲食品
DE102006044849A1 (de) * 2006-09-22 2008-04-03 Symrise Gmbh & Co. Kg Dekonjugierte Alkadiensäureester als Riech- und/oder Aromastoffe

Also Published As

Publication number Publication date
US8623916B2 (en) 2014-01-07
CA2747681A1 (fr) 2010-07-01
WO2010072738A1 (fr) 2010-07-01
US20110230557A1 (en) 2011-09-22
BRPI0923494B1 (pt) 2017-04-18
MA32810B1 (fr) 2011-11-01
AU2009331526B2 (en) 2013-10-24
HK1163655A1 (en) 2012-09-14
JP5587333B2 (ja) 2014-09-10
RU2011128264A (ru) 2013-01-27
MX2011006659A (es) 2011-07-12
GEP20135820B (en) 2013-05-10
CN102256930A (zh) 2011-11-23
IL213646A (en) 2014-03-31
FR2940281B1 (fr) 2011-04-01
PT2379484E (pt) 2013-08-22
SG172342A1 (en) 2011-07-28
JP2012513380A (ja) 2012-06-14
PL2379484T3 (pl) 2013-10-31
ZA201103509B (en) 2012-01-25
EP2379484A1 (fr) 2011-10-26
KR20110101152A (ko) 2011-09-15
TN2011000237A1 (fr) 2012-12-17
EP2379484B1 (fr) 2013-05-29
BRPI0923494A2 (pt) 2016-01-26
ES2424088T3 (es) 2013-09-27
UA103645C2 (uk) 2013-11-11
MY151002A (en) 2014-03-31
CO6390033A2 (es) 2012-02-29
NZ593781A (en) 2013-02-22
CN102256930B (zh) 2014-03-12
AU2009331526A1 (en) 2010-07-01
CA2747681C (fr) 2017-05-16
FR2940281A1 (fr) 2010-06-25
RU2524779C2 (ru) 2014-08-10
KR101676055B1 (ko) 2016-11-14
IL213646A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
CL2019003105A1 (es) Lípidos extraídos de plantas que comprenden ácidos grasos poliinsaturados de cadena larga. (divisional solicitud 201601560)
CL2019002477A1 (es) Producción de ácidos graso poliinsaturados de cadena larga en células vegetales. (divisional solicitud 201403402)
CL2011002745A1 (es) Compuestos derivados de acidos grasos poliinsaturados; metodo de preparacion; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de trastornos cardiovasculares, metabolicos e inflamatorios, tales como, artritis reumatoide, aterosclerosis, diabetes, dislipidemia, entre otras.
CL2019002663A1 (es) Producción de ácidos grasos poliinsaturados de cadena larga en células vegetales. (divisional solicitud 201702448)
PE20150770A1 (es) Metodos para reducir el riesgo de un evento cardiovascular en un sujeto con terapia con estatina
PE20142367A1 (es) Formulaciones de imiquimod
UY32204A (es) Composiciones farmacéuticas que contienen diacereína
BR112012023421A2 (pt) composição farmacêutica para tratamento de aumento de pressão intraocular
NZ702325A (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
UA107682C2 (uk) Жир із соняшника з високою температурою плавлення для кондитерських виробів
CL2011001539A1 (es) Compuestos derivados de un acido graso poliinsaturado omega 3 u omega 6 y un ester de diol con actividad anti-inflamatoria y antibacteriana; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento del acne o la dermatitis seborreica.
MX342216B (es) Composiciones de acidos grasos.
BR112013004734A2 (pt) "conversão de óleos vegetais a óleos básicos e combustíveis de transporte."
BR112017001404A2 (pt) tioesterases variantes e métodos de utilização
AR086082A1 (es) Un proceso para la esterificacion autocatalitica de acidos grasos
BR112014032741A2 (pt) lipase em esterificação de ácidos graxos de cadeia curta
BR112015025523A2 (pt) preparação de lactilatos diretamente do óleo
MY157705A (en) Emulsified fats and oils composition
BR112014018682A8 (pt) Processo para produção de ácidos graxos, sn-regio mono-acilglicerol (mag), sn- regio diacil-gliceróis (dag) e glicerol; e processo para produção de ácidos graxos e glicerol
BR112012033104A2 (pt) composições de gordura de fornecimento de textura sem têmpera
PE20140810A1 (es) Concentrado de omega 3
EP3563690A3 (en) Dihomo-gamma-linolenic acid-containing microbial oil and dihomo-gamma-linolenic acid-containing microbial biomass
BR112014009333A2 (pt) processo para produzir um éster de ácido graxo epoxidizado a partir de uma gordura ou óleo natural epoxidizado
AR071699A1 (es) Uso de lisofosfolipidos para tratar la inflamacion. composicion.
CL2014002244A1 (es) Proceso para mejorar la eficiencia de alimentación y características de la canal de los animales, que comprende tratar al animal con una composicion que contiene desde 2 a 76% en peso de al menos un triglicerido con al menos un acido graso hidroxilado y 24 a 95% de liquido de la cascara de nuez de anacardo.